Open the map

Baxter InternationalBAX

Medtech & devices · NYSE · USA

$23.90
Down 0.3% todayClose

Up 25.4% this year and +8.4% since June 26, behind the life science sector at +10.7%. Baxter International supplies 1 mapped company.

This year
+25.4%
1 year
+4.7%
P/E
n/a
P/S
1.1
P/B
2.0

Price vs the life science sector

since Jun 26BAXLife science sector, equal weight
Baxter International (BAX) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. BAX: +8.4% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+10%+20%+30%Jun 26AugSepOct 8BAX +8.4%Sector +10.7% Baxter International (BAX) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. BAX: +8.4% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+10%+20%+30%Jun 26AugSepOct 8BAX+8.4%Sector+10.7%

Supply chain

1 customer
SUPPLIERS →→ CUSTOMERSNone mappedCardinal Health (CAH)CAHCardinal Health+2.9%BAXBaxter Internat… Open the full chain →

About Baxter International

Infusion pumps and the fluids that run through them are the anchor. Baxter also supplies dialysis therapy and products for surgery and acute care.

Theme exposure

Hospital productsInfusionRenal care

Products

  • Infusion pumps & fluids
  • Renal/dialysis therapy
  • Surgery & acute care

Competitors

Risks

  • Hospital budgets
  • Debt & restructuring

Same segment: Medtech & devices

Medical equipment and devices, from surgery and cardiology to robotics. Segment 7 of 8 in the Medicine, pharma & life science value chain.

Compare BAX

Side by side with the largest companies in the same segment.

See where Baxter International sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →